Mechanisms of ADAMTS13 regulation
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15873
Abstract: Recombinant ADAMTS13 is currently undergoing clinical trials as a treatment for hereditary thrombotic thrombocytopenic purpura, a lethal microvascular condition resulting from ADAMTS13 deficiency. Preclinical studies have also demonstrated its efficacy in treating arterial thrombosis and… read more here.
Keywords: mechanisms adamts13; regulation; adamts13 regulation; adamts13 ... See more keywords